Investigation of relapse to opioid use after withdrawal. Opioid related disorders
Conditions
Interventions
Intervention 1: Intervention group: Clients 18 to 65 years of age with a history of at least two failed disuse treated with 0.18 mm Pramipexole tablets twice daily for two weeks and then increasing t
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: meet the criteria of DSM-V for opioid use disorder have failed to reduce or abstain currently abused opioid at least for 2 times have negative urine analysis for other addictive substances or the history of co-administration of drugs of abuse for no less than 3 weeks ago
Exclusion criteria
Exclusion criteria: have been diagnosed by severe comorbid medical or psychiatric disorders (Parkinson’s disease, cardiovascular disorders, metabolic syndrome, bipolar disorder, schizophrenia, renal impairment, and so on); have taken psychiatric medications within the last 2 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of craving. Timepoint: Frequency of craving at the beginning of research; after 4 and 6 months. Method of measurement: Measuring the temptation to use drugs after quitting questionnaire.;Days of not abusing drugs. Timepoint: Frequency of craving at the beginning of research; after 4 and 6 months. Method of measurement: Self-report.;Negative urine test. Timepoint: At the beginning of research; 2 times randomly during the research. Method of measurement: Urine test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohre zand kargar
Kerman University of Medical Sciences
Outcome results
None listed